Oncolytic viruses have been taking the front stage in biological therapy for cancer recently.
The first and most potent virus to be used in oncolytic virotherapy is human adenovirus …

Adenoviral vector has been employed as one of the most efficient means against infectious
diseases and cancer. It can be genetically modified and armed with foreign antigens to elicit …

Non-human primate (NHP)-derived adenoviruses have formed a valuable alternative for the
use of human adenoviruses in vaccine development and gene therapy strategies by virtue of …

The use of human adenoviruses (hAds) as oncolytic agents has demonstrated considerable
potential. However, their efficacy in clinical studies is generally moderate and often varies …

Survivin holds significant importance as a member of the inhibitor of apoptosis protein (IAP)
family due to its predominant expression in tumours rather than normal terminally …

Although a canine adenovirus (CAdV)-based oncolytic virus (OV) candidate targeting canine
tumors has been reported, its oncolytic effect could be attenuated by CAdV vaccine-induced …

Oncolytic adenoviruses derived from human serotype 5 (Ad5) are being developed to treat
cancer. Treatment efficacy could be affected by pre-existing or induced neutralizing …

In the last few decades, Ebola virus (EBOV) has emerged periodically and infected people in
Africa, resulting in an extremely high mortality rate. With no available prophylaxis or cure so …

According to the World Health Organization, cancer is the second leading cause of death in
the world. This serves as a powerful incentive to search for new effective cancer treatments …

По данным Всемирной организации здравоохранения онкологические заболевания
занимают второе место по смертности в мире. Это обстоятельство является мощным …